EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beyond antigenic variation: A review of innovative immuno-epidemiologic approaches to trypanosomiasis vaccine design

Franklyn Ayomide Oluwadare, Olamilekan Gabriel Banwo, Terese Gabriel Orum, Adeola Mariam Lateef, Mark Musa Hamman, Victor Ibukun Agbajelola

Przeglad Epidemiologiczny · 08.04.2026

DOI: 10.32394/pe/219850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Przeglad Epidemiologiczny, online erschienen am 08.04.2026. Verfasst von Franklyn Ayomide Oluwadare und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Production and Quality Control Program, Pan African University Life and Earth Sciences Institute, Including Health and Agriculture - PAULESI,…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trypanosomiasis remains a major neglected tropical disease, largely uncontrolled due to rising drug resistance and the absence of an effective vaccine. Decades of vaccine failure are primarily linked to the parasite’s immune-evasion strategy of Antigenic Variation (AV), driven by continual switching of the Variant Surface Glycoprotein (VSG) coat. This review proposes an integrated immuno-epidemiologic framework that moves beyond VSG-focused strategies by targeting conserved functional vulnerabilities and incorporating population-level transmission dynamics. The approach redirects vaccine development toward invariant, indispensable antigens such as the Transferrin Receptor (TfR), Invariant Surface Glycoproteins (ISGs), and Paraflagellar Rod (PFR) components. Antibodies against these molecules can induce conserved killing mechanisms, including iron starvation or disruption of essential membrane functions – regardless of VSG switching. Advances in reverse vaccinology enable multi-epitope and mRNA platforms to encode these structurally constrained targets, while complementary transmission-blocking and vector-focused strategies aim to interrupt parasite development within tsetse flies. A central argument is that partially protective vaccines (PPVs) can produce substantial epidemiologic benefits by lowering parasitemia, shortening infectious duration, and reducing the probability of vector infection. Such effects can meaningfully suppress transmission without requiring sterilizing immunity. A One Health approach, coupled with realistic population-based efficacy metrics, is essential for future vaccine development. By exploiting conserved molecular constraints and integrating immunologic, ecological, and epidemiologic insights, this framework outlines a practical pathway toward effective trypanosomiasis vaccination.

Schlagwörter

Stichwörter der Autor:innen

One Healthantigenic variationimmuno-epidemiologytrypanosomiasisvaccines

Autor:innen und Institutionen

  • Vaccine Production and Quality Control Program, Pan African University Life and Earth Sciences Institute, Including Health and Agriculture - PAULESI, University of Ibadan, Oyo State, Nigeria.
  • African Infectious Disease and Epidemiology Group, (AIDEG), Nigeria.
  • Department of Veterinary Medicine, Faculty of Veterinary Medicine, University of Ibadan, Oyo State, Nigeria.
  • School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom.
  • Department of Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia - Missouri, USA.

Zitieren

APA

Oluwadare, F. A., Banwo, O. G., Orum, T. G., Lateef, A. M., Hamman, M. M., & Agbajelola, V. I. (2026). Beyond antigenic variation: A review of innovative immuno-epidemiologic approaches to trypanosomiasis vaccine design. Przeglad Epidemiologiczny. https://doi.org/10.32394/pe/219850

Vancouver

Oluwadare FA, Banwo OG, Orum TG, Lateef AM, Hamman MM, Agbajelola VI. Beyond antigenic variation: A review of innovative immuno-epidemiologic approaches to trypanosomiasis vaccine design. Przeglad Epidemiologiczny. 2026. doi:10.32394/pe/219850

BibTeX
@article{Oluwadare2026,
  author = {Oluwadare, Franklyn Ayomide and Banwo, Olamilekan Gabriel and Orum, Terese Gabriel and Lateef, Adeola Mariam and Hamman, Mark Musa and Agbajelola, Victor Ibukun},
  title = {Beyond antigenic variation: A review of innovative immuno-epidemiologic approaches to trypanosomiasis vaccine design},
  journal = {Przeglad Epidemiologiczny},
  year = {2026},
  doi = {10.32394/pe/219850}
}
Kostenlos starten →